Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Umezawa

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
The Journal of Antibiotics|April 1, 1985
N-Substituted derivatives of 23-amino-4',23-dideoxymycaminosyl tylonolide. Synthesis and antibacterial activityS Sakamoto, T Tsuchiya, A Tanaka, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|March 1, 1994
Alkaline soluble Trypanosoma cruzi epimastigote antigen (ASEA) applied to Dot-ELISAA M Lissaldo, S Hoshino-Shimizu, E S Umezawa, et al.
International Journal of Oncology|May 12, 2011
Effect of rhg-csf (filgrastim) on leukocyte kinetics and immune function in cytotoxic chemotherapy for gynecologic malignanciesN Takeshima, S Umezawa, Y Shimizu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinomaY Shimizu, F Akiyama, S Umezawa, et al.
Journal of Clinical Microbiology|June 1, 1995
High specificity of Trypanosoma cruzi epimastigote ribonucleoprotein as antigen in serodiagnosis of Chagas' diseaseM E Solana, A M Katzin, E S Umezawa, et al.
The Journal of Antibiotics|April 1, 1980
Syntheses of corliolin, 1-deoxy-1-ketocoriolin and 1,8-dideoxy-1,8-diketocoriolin from coriolin BY Nishimura, Y Koyama, S Umezawa, et al.
Journal of Clinical Laboratory Analysis|April 3, 1998
Reactivity of chagasic antigal antibodies with noninfected cells treated with Trypanosoma cruzi secreted/excreted antigensJ K Yokoyama-Yasunaka, R M Piazza, E S Umezawa, et al.
Drugs Under Experimental and Clinical Research|January 1, 1988
Biological properties of ME2303 (FAD-104), a new anthracyclineS Omoto, S Kondo, S Fukatsu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1996
[Report of nationwide questionnaire: intraperitoneal chemotherapy for advanced ovarian cancer based on clinical results--reports of 5th "Gynecologic Intraperitoneal Chemotherapy Study Group" meeting]S Umezawa, Y Shimizu, K Takizawa, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 1, 1989
Heterogeneity of big-big hPRL in hyperprolactinemiaT Tanaka, H Yano, S Umezawa, et al.
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
The Journal of Antibiotics|April 1, 1985
N-Substituted derivatives of 23-amino-4',23-dideoxymycaminosyl tylonolide. Synthesis and antibacterial activityS Sakamoto, T Tsuchiya, A Tanaka, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|March 1, 1994
Alkaline soluble Trypanosoma cruzi epimastigote antigen (ASEA) applied to Dot-ELISAA M Lissaldo, S Hoshino-Shimizu, E S Umezawa, et al.
International Journal of Oncology|May 12, 2011
Effect of rhg-csf (filgrastim) on leukocyte kinetics and immune function in cytotoxic chemotherapy for gynecologic malignanciesN Takeshima, S Umezawa, Y Shimizu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinomaY Shimizu, F Akiyama, S Umezawa, et al.
Journal of Clinical Microbiology|June 1, 1995
High specificity of Trypanosoma cruzi epimastigote ribonucleoprotein as antigen in serodiagnosis of Chagas' diseaseM E Solana, A M Katzin, E S Umezawa, et al.
The Journal of Antibiotics|April 1, 1980
Syntheses of corliolin, 1-deoxy-1-ketocoriolin and 1,8-dideoxy-1,8-diketocoriolin from coriolin BY Nishimura, Y Koyama, S Umezawa, et al.
Journal of Clinical Laboratory Analysis|April 3, 1998
Reactivity of chagasic antigal antibodies with noninfected cells treated with Trypanosoma cruzi secreted/excreted antigensJ K Yokoyama-Yasunaka, R M Piazza, E S Umezawa, et al.
Drugs Under Experimental and Clinical Research|January 1, 1988
Biological properties of ME2303 (FAD-104), a new anthracyclineS Omoto, S Kondo, S Fukatsu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1996
[Report of nationwide questionnaire: intraperitoneal chemotherapy for advanced ovarian cancer based on clinical results--reports of 5th "Gynecologic Intraperitoneal Chemotherapy Study Group" meeting]S Umezawa, Y Shimizu, K Takizawa, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 1, 1989
Heterogeneity of big-big hPRL in hyperprolactinemiaT Tanaka, H Yano, S Umezawa, et al.
Pageof 11